Business, energy, technology, markets and global industry news from Business News Today

risk stratification

PharmaDeviceNews risk stratification
Representative image of AI-powered digital pathology being used to analyse prostate cancer biopsy slides, reflecting Acupath Laboratories’ integration of the ArteraAI Prostate Test into its diagnostic workflow for localized prostate cancer risk stratification.
Medical Devices & Diagnostics

What Acupath’s ArteraAI Prostate Test rollout reveals about the next phase of precision oncology

Acupath adds ArteraAI Prostate Test to its pathology workflow. Find out what it means for AI prostate cancer risk stratification today.

Read More
Representative image: AI-powered digital pathology analysis could help reshape breast cancer risk stratification after ArteraAI Breast became the first FDA-cleared pathology-based breast cancer risk tool in the United States.
Medical Devices & Diagnostics

Can ArteraAI Breast turn routine pathology slides into breast cancer risk intelligence?

AI can read pathology slides, but can it change breast cancer treatment decisions? ArteraAI Breast puts that question before clinicians and payers.

Read More